| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ABIOMED INC | 2,150,000 | 199,434,000 | 36.46% | ||
| 2 | REVANCE THERAPEUTICS INC COM | 4,592,047 | 136,659,000 | 24.98% | ||
| 3 | CORIUM INTERNATIONAL INC | 9,353,304 | 87,453,000 | 15.99% | ||
| 4 | ENTELLUS MEDICAL INC | 3,813,197 | 68,714,000 | 12.56% | ||
| 5 | ENDOLOGIX INC | 1,257,468 | 21,220,000 | 3.88% | ||
| 6 | AXOGEN INC | 4,861,111 | 20,028,000 | 3.66% | ||
| 7 | Catalyst Biosciences | 1,179,352 | 5,658,000 | 1.03% | ||
| 8 | ACURA PHARMACEUTICALS INC | 1,956,397 | 4,598,000 | 0.84% | ||
| 9 | MEDICINOVA INC COM NEW | 1,170,370 | 3,289,000 | 0.60% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-15-001986, filed 2015.11.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
